|
Expert consensus on the construction of specialized outpatient clinics and standardized case management of children with atopic dermatitis in China (2025 version)
Group on Children, Chinese Society of Dermatology, Dermatology and Venereology Group, Chinese Pediatric Society, Chinese Medical Association, Chinese Association of Rehabilitation Dermatology, Pediatric Dermatology Group, China Dermatologist Association
Chinese Journal of Dermatology
2025, 0 (4):
20240338-e20240338.
DOI: 10.35541/cjd.20240338
Accepted: 12 March 2025
【Abstract】 Atopic dermatitis (AD) is the most common chronic inflammatory disease in dermatology, often beginning in infancy. It can recur and persist into childhood and adolescence, severely affecting sleep, growth and development of children, impairing the quality of life of both the children and their families, and imposing significant social and economic burden. In recent years, the prevalence of AD among children in China has been rising. However, the diagnosis and treatment vary widely across different regions and medical institutions. Meanwhile, there is a lack of evidence?based medicine specific to Chinese children with AD in real?world settings, and the concepts and measures for chronic disease management of AD have not been widely established. To promote the establishment of specialized AD clinics in pediatric dermatology in China, enhance clinical diagnosis and treatment, standardize treatment processes, reduce the disease burden, and improve the quality of life of children and their families, the Group on Children, Chinese Society of Dermatology, the Dermatology and Venereology Group, Chinese Pediatric Society, Chinese Medical Association, the Chinese Association of Rehabilitation Dermatology, and the Pediatric Dermatology Group, China Dermatologist Association organized domestic experts for extensive surveys and discussions. Combining international guidelines with the situation in China, this consensus was formed to provide a reference for the construction of specialized AD clinics in pediatric dermatology in China, and enhance the capability to provide comprehensive care for children with AD throughout the entire disease course.
Reference |
Related Articles |
Metrics
|
|